Bionpharma Inc Company Profile

What is the competitive landscape for BIONPHARMA INC, and what generic alternatives to BIONPHARMA INC drugs are available?

BIONPHARMA INC has forty-eight approved drugs.

There are five US patents protecting BIONPHARMA INC drugs.

There are ten patent family members on BIONPHARMA INC drugs in thirteen countries and seventy-four supplementary protection certificates in fourteen countries.

Summary for Bionpharma Inc

International Patents:	10
US Patents:	5
Tradenames:	45
Ingredients:	41
NDAs:	48
Drug Master File Entries:	2
Patent Litigation for Bionpharma Inc:	See patent lawsuits for Bionpharma Inc

Drugs and US Patents for Bionpharma Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bionpharma Inc	LOPERAMIDE HYDROCHLORIDE	loperamide hydrochloride	CAPSULE;ORAL	021855-001	Aug 4, 2005		OTC	Yes	No
Bionpharma Inc	DOFETILIDE	dofetilide	CAPSULE;ORAL	208625-002	Apr 10, 2018	AB	RX	No	No
Bionpharma Inc	IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE	diphenhydramine hydrochloride; ibuprofen	CAPSULE;ORAL	090397-001	Nov 22, 2010		OTC	No	No
Bionpharma Inc	FLUVOXAMINE MALEATE	fluvoxamine maleate	CAPSULE, EXTENDED RELEASE;ORAL	212182-002	Sep 16, 2020	AB	RX	No	No
Bionpharma Inc	DROXIDOPA	droxidopa	CAPSULE;ORAL	213033-002	Apr 28, 2021	AB	RX	No	No
Bionpharma Inc	AMPHETAMINE SULFATE	amphetamine sulfate	TABLET;ORAL	212919-002	Nov 22, 2019	AA	RX	No	No
Bionpharma Inc	ZONISAMIDE	zonisamide	CAPSULE;ORAL	077813-003	Aug 16, 2006	AB	RX	No	No

Expired US Patents for Bionpharma Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bionpharma Inc	MIDOL LIQUID GELS	ibuprofen	CAPSULE;ORAL	021472-001	Oct 18, 2002	6,251,426

International Patents for Bionpharma Inc Drugs

Country	Patent Number	Estimated Expiration
Portugal	1863458
Poland	1863458
Mexico	2007011039
China	102940887
World Intellectual Property Organization (WIPO)	2006096580
European Patent Office	3061447
Canada	2600023

Supplementary Protection Certificates for Bionpharma Inc Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0716606	SPC/GB02/011	United Kingdom		PRODUCT NAME: SEVELAMER; REGISTERED: UK EU/1/99/120/001-004 20000202
0914118	SPC/GB07/002	United Kingdom		SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB07/002 GRANTED TO NOVARTIS AG IN RESPECT OF THE PRODUCT DEFERASIROX AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, ESPECIALLY 4-(3,5-BIS(2-HYDROXYPHENYL)-(1,2,4) TRIAZOL-L-YL) BENZOIC ACID, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6179 DATED 24 OCTOBER 2007 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 30 AUGUST 2021.
0716606	C300428	Netherlands		PRODUCT NAME: SEVELAMER CARBONAAT OF BICARBONAAT; REGISTRATION NO/DATE: EU/1/09/521/001-007 20090610
0245997	C300002	Netherlands		PRODUCT NAME: DOFETILIDE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/99/121/001 - EU/1/99/121/015 19991129
1441735	08C0026	France		PRODUCT NAME: RALTEGRAVIR POTASSIUM; REGISTRATION NO/DATE: EU/1/07/436/001 20080102
1441735	2008/010	Ireland		PRODUCT NAME: RALTEGRAVIR OR A PHARMECEUTICALLY ACCEPTABLE SALT THEREOF, ESPECIALLY THE POTASSIUM SALT; NAT AUTHORISTION NO/DATE: EU/1/07/436/001-002 20071220;
0984957	PA2011005,C0984957	Lithuania		PRODUCT NAME: NAPROXENUM + ESOMEPRAZOLUM; REGISTRATION NO/DATE: LT/1/10/2302/001-LT/1/10/2302/012 20110126

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Bionpharma Inc